Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...

Pfizer Inc (PFE) announced an update on their ongoing clinical study.

Pfizer is steering much of its pandemic revenue into oncology, as Chief Executive Albert ...

Also: All the news and watercooler chat from Fortune.

Both could reward patient investors down the line.

Pfizer has lagged the broader market over the past year, and analysts remain cautious about its future outlook.

LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with Donald Trump's administration to ...

Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental COVID-19 pill. The agreement with the Medicines Patent Pool, a United Nations-backed public ...

Pfizer’s multi-year effort to stabilize its U.S. penicillin supply has hit an unexpected hitch after particulate concerns prompted a recall of the company’s long-acting injectable form of the ...

PHILADELPHIA (WPVI) -- A local researcher from Penn Medicine says there's reason to believe at least one other potential coronavirus vaccine could be as effective as Pfizer's vaccine is said to be.

Pfizer's second-quarter results were better than expected. The drugmaker will still face some near-term uncertainty. However, its long-term prospects look attractive, especially at current levels.

AI in drug discovery offers key market opportunities by enhancing drug development efficiency, reducing costs, and improving success rates. It supports personalized medicine, facilitating custom ...